T. Rowe Price Associates’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-59,906
| Closed | -$21K | – | 2603 |
|
|
2016
Q3 | $21K | Sell |
59,906
-994
| -2% | -$348 | ﹤0.01% | 2518 |
|
|
2016
Q2 | $28K | Buy |
60,900
+1,000
| +2% | +$460 | ﹤0.01% | 2498 |
|
|
2016
Q1 | $81K | Hold |
59,900
| – | – | ﹤0.01% | 2435 |
|
|
2015
Q4 | $88K | Buy |
59,900
+500
| +0.8% | +$735 | ﹤0.01% | 2438 |
|
|
2015
Q3 | $94K | Hold |
59,400
| – | – | ﹤0.01% | 2416 |
|
|
2015
Q2 | $101K | Hold |
59,400
| – | – | ﹤0.01% | 2456 |
|
|
2015
Q1 | $83K | Sell |
59,400
-25,000
| -30% | -$34.9K | ﹤0.01% | 2484 |
|
|
2014
Q4 | $127K | Buy |
84,400
+38,600
| +84% | +$58.1K | ﹤0.01% | 2442 |
|
|
2014
Q3 | $94K | Hold |
45,800
| – | – | ﹤0.01% | 2477 |
|
|
2014
Q2 | $140K | Buy |
+45,800
| New | +$140K | ﹤0.01% | 2426 |
|